Publications

This fact sheet contains information for prescribers on the changes to vaping in Australia.

This certification statement, signed by Secretary Blair Comley on 25 September 2024, certifies that the PBS Education campaign complies with relevant guidelines and policies.

The list of variants for sickle cell disease, beta thalassemia and other hemoglobinopathies are captured in this resource.

This publication includes information published in accordance with subsection 53B(5) of the
Medical Indemnity Act 2002. It also includes information reported to the Secretary of the Department of Health and Aged Care in accordance with section 20 of the Medical Indemnity Rules 2020.

This infographic shows the number of flu (influenza) vaccinations reported to the Australian Immunisation Register (AIR) during 2021–2024, since 1 March.

This fact sheet provides aged care assessors with an overview of sharing My Aged Care support plans with My Health record, including their responsibility to ask for and record consent.

This document provides information for assessors about My Health Record, asking for and recording content, key contacts and useful links.

Aged care assessors should print this fact sheet and give it to older people during aged care assessments. It provides information for older people about sharing My Aged Care support plans with My Health record.

Aged care assessors can print this document and give it to older people during assessments. It provides information for older people about My Aged Care support plans, My Health Record, sharing support plans with My Health Record, key contacts and useful links.

This document provides information for healthcare providers about My Aged Care support plans being available in My Health Record.

The ATAGI 2024 Annual Statement on Immunisation is the fourth publication in this series. The statement highlights the key successes, trends and challenges in the use of vaccines and control of vaccine preventable diseases in Australia in 2023, and includes advice to address key issues for 2024.

This fact sheet contains information for parents and carers on the changes to vaping in Australia.

This fact sheet contains information on the changes to vaping in Australia.

Treating physicians use this application form to apply for a patient to access LSDP medication for hereditary tyrosinaemia (type 1) for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for Pompe disease for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS I for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS II for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS IVA for the first time, or after a break.

Treating physicians use this application form to apply for a patient to access LSDP medication for MPS VI for the first time, or after a break.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Gaucher disease.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for hereditary tyrosinaemia (type 1).

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Batten disease.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for Pompe disease.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS I.

Treating physicians use this form to reapply each year for a patient to receive ongoing LSDP medication for MPS II.